Promise Proteomics
Mass spectrometry protein and monoclonal antibody quantification products for clinical and bioanalytical laboratories
Highlights
- New on EvolcAdded 2026-10-30
About Promise Proteomics
Promise Proteomics develops mass spectrometry-based products and solutions for quantitative proteomics. Its offerings include mAb quantification kits, stable-isotope-labelled proteins and monoclonal antibodies, and custom production of labelled proteins and antibodies.
Its products serve healthcare professionals and bioanalytical scientists, including laboratories using LC-MS assays. The company also develops and manufactures research and in-vitro diagnostic products.
Promise Proteomics was founded in 2010 and is based in Grenoble, France, where its SIL products are produced. It holds ISO 9001 and ISO 13485 certifications.
Product: Mass spectrometry-based antibody quantification kits, stable-isotope-labelled proteins and antibodies, and custom bioproduction services.
Jobs at Promise Proteomics
More biotech & pharma companies
Proteogenix
Antibody discovery, engineering and early-development services for biotech, pharmaceutical, diagnostic, veterinaryNew on EvolcProvepharm
Develops medical dyes for healthcare professionals performing precision surgery and clinical proceduresNew on EvolcQubit Pharmaceuticals
Develops AI- and quantum-enabled drug discovery tools and therapeutics for pharmaceutical partners and patients with major diseasesNew on EvolcRoowin
Fine chemistry and cGMP drug-development services for pharmaceutical, biotechnology, and fine chemical companiesNew on EvolcScreencell
Patented CTC isolation kits that enrich circulating tumor cells from whole blood for cancer researchers and laboratoriesNew on EvolcSensorion
Biotechnology company developing therapies for people with hearing loss and inner ear disordersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- HubSpot
- HubSpot CMS
- WooCommerce
- WordPress
- jQuery
